Tower Research Capital LLC (Trc) Aravive, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.11 - $0.22 $38 - $76	-348 Reduced 1.33%	25,744 $3,000
Q3 2023 Nov 14, 2023	BUY	$0.11 - $1.76 $1,669 - $26,711	15,177 Added 139.05%	26,092 $3,000
Q2 2023 Aug 14, 2023	BUY	$1.25 - $1.92 $10,625 - $16,320	8,500 Added 351.97%	10,915 $13,000
Q1 2023 May 09, 2023	SELL	$1.29 - $2.46 $23,876 - $45,532	-18,509 Reduced 88.46%	2,415 $5,000
Q4 2022 Feb 10, 2023	BUY	$1.2 - $1.83 $7,606 - $11,600	6,339 Added 43.46%	20,924 $27,000
Q3 2022 Nov 10, 2022	BUY	$0.61 - $1.03 $1,620 - $2,736	2,657 Added 22.28%	14,585 $12,000
Q2 2022 Aug 15, 2022	BUY	$0.93 - $1.9 $9,915 - $20,257	10,662 Added 842.18%	11,928 $12,000
Q1 2022 May 12, 2022	SELL	$1.85 - $2.75 $6,737 - $10,015	-3,642 Reduced 74.21%	1,266 $2,000
Q4 2021 Feb 14, 2022	BUY	$2.19 - $4.07 $8,933 - $16,601	4,079 Added 492.04%	4,908 $11,000
Q3 2021 Nov 15, 2021	BUY	$3.67 - $5.8 $418 - $661	114 Added 15.94%	829 $3,000
Q2 2021 Aug 16, 2021	SELL	$4.65 - $6.42 $59,310 - $81,887	-12,755 Reduced 94.69%	715 $4,000
Q1 2021 May 17, 2021	BUY	$5.11 - $9.24 $48,095 - $86,966	9,412 Added 231.94%	13,470 $89,000
Q4 2020 Feb 16, 2021	SELL	$4.36 - $6.51 $32,194 - $48,069	-7,384 Reduced 64.53%	4,058 $23,000
Q3 2020 Nov 16, 2020	BUY	$4.7 - $12.06 $20,675 - $53,051	4,399 Added 62.46%	11,442 $54,000
Q2 2020 Aug 13, 2020	BUY	$5.18 - $14.81 $31,613 - $90,385	6,103 Added 649.26%	7,043 $82,000
Q1 2020 May 15, 2020	SELL	$3.5 - $13.77 $2,810 - $11,057	-803 Reduced 46.07%	940 $5,000
Q4 2019 Feb 07, 2020	BUY	$6.21 - $14.02 $9,445 - $21,324	1,521 Added 685.14%	1,743 $24,000
Q3 2019 Nov 05, 2019	BUY	$5.2 - $8.68 $1,029 - $1,718	198 Added 825.0%	222 $2,000
Q2 2019 Aug 13, 2019	BUY	$5.65 - $7.5 $135 - $180	24 New	24 $0
Q1 2019 May 14, 2019	SELL	$3.35 - $8.27 $7,098 - $17,524	-2,119 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.23 - $8.7 $6,844 - $18,435	2,119 New	2,119 $7,000

Others Institutions Holding ARAV

# of Institutions

Shares Held

28.1K

Call Options Held

Put Options Held

View Full List

About Aravive, Inc.

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

More about ARAV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account